# Enhanced Inhibition of Trametes versicolor by Structurally Modified Medicarpin: In Vitro Evaluation and In Silico Insights into Laccase Binding

**Authors:** Santiago José Guevara-Martínez, José Domingo Rivera-Ramírez, Rebeca Escutia-Gutiérrez, Marco Antonio Pérez-Cisneros, Francisco Villanueva-Mejía, Stephanie García-Zavala, Rafael Herrera-Bucio, Fredy Geovannini Morales-Palacios

PMC · DOI: 10.3390/ijms27062878 · International Journal of Molecular Sciences · 2026-03-22

## TL;DR

Scientists improved a natural compound's ability to inhibit a wood-destroying fungus by modifying its structure and studying its binding to a key enzyme.

## Contribution

A structurally modified form of medicarpin was shown to inhibit Trametes versicolor more effectively through improved laccase binding.

## Key findings

- An acetylated medicarpin derivative inhibited T. versicolor growth completely at 100 mg/L.
- Molecular docking and simulations showed the derivative binds more favorably to laccase's copper cluster.
- The modification improved binding stability and interactions at the enzyme's active site.

## Abstract

Medicarpin, a natural pterocarpan phytoalexin, contributes to tree defense against microbial decay, particularly from the aggressive white-rot fungus Trametes versicolor, an ASTM standard for wood durability testing. To improve upon the inhibitory effect of medicarpin against this fungus (150 mg/L), eleven derivatives were synthesized and evaluated. The acetylated analog demonstrated superior activity, achieving complete growth inhibition at 100 mg/L. To establish a structure–activity relationship, molecular docking was performed on the copper cluster on fungal laccase, the primary oxidative enzyme of T. versicolor. The acetylated derivative bound the T1 copper site with a more favorable free energy (−8.5 kcal/mol) than the parent compound, exhibiting enhanced stabilizing interactions and a binding pose anchored closer to the trinuclear copper cluster (TNC). These results were corroborated by 80 ns molecular dynamics simulations, confirming complex stability and the persistence of key interactions. This study demonstrates that targeted chemical modification of natural phytoalexins can significantly improve their antifungal potency. The superior performance of the acetylated medicarpin derivative, linked to optimized binding at the laccase active site, establishes a clear structure–activity relationship and highlights the potential of such engineered compounds as leads for next-generation, bio-inspired wood preservatives.

## Linked entities

- **Proteins:** LOC7454935 (laccase-2)
- **Chemicals:** medicarpin (PubChem CID 73067)
- **Species:** Trametes versicolor (taxon 5325)

## Full-text entities

- **Chemicals:** Medicarpin (MESH:C047353), copper (MESH:D003300), Silico (-)
- **Species:** Trametes versicolor (turkey-tail fungus, species) [taxon 5325]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC13026702/full.md

## Figures

18 figures with captions in the complete paper: https://tomesphere.com/paper/PMC13026702/full.md

## References

78 references — full list in the complete paper: https://tomesphere.com/paper/PMC13026702/full.md

---
Source: https://tomesphere.com/paper/PMC13026702